Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsAiforia® Breast Cancer PR

Vendor source

Reviewed 11 May 2026

Completeness Good (56%)

Aiforia® Breast Cancer PR

Aiforia Technologies Plc

Aiforia® Breast Cancer PR automatically detects invasive carcinoma and quantifies PR-positive and PR-negative cells in whole slide images (WSI) or selected tissue regions. The aim of the software is to enhance diagnostic clarity and improve workflow efficiency.

No papers to support — we monitor for new evidence.

Aiforia® Breast Cancer PR

Key Features

  • Breast cancer detection
  • Quantification of PR-positive and negative tumor cells

General Information

Product name

Aiforia® Breast Cancer PR

Modality

Histopathology

Main task

Scoring (IHC quantification)

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Not specified

Staining

IHC

Stain subtype

PR

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

whole-slide image, PR IHC

Input format

Not specified

Output

segmentation overlays, object detection overlays, assessment of pathology presence, quantitative area measurements and object counts, automated scoring, draft histopathology report

Output format

Not specified

Integration

Integration via AI marketplace or distribution platform, Integration with hospital reporting system, Integration with IMS (Image Management System), Integration with LMS (Laboratory Management System), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

Not specified

Population

Species: Human, Organ: Breast

Viewer systems

Not specified

Market Presence

On market since

12-2023

AI Platforms

Sectra Amplifier Store

Resellers

Gaia Science, LIN Trading, Mediq Estonia, Ortomedic, Palex Medical, Quorum Technologies, TeSi Group, Urban Datalab

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Vendor | First published: Jul 30, 2025 | Last updated: May 11, 2026

Aiforia® Breast Cancer PR - Aiforia Technologies Plc